| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30058346 | HIV | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS30058347 | HIV | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS20036174 | HPV | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS20019756 | HPV | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS44005617 | HTLV-1 | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS44024963 | HTLV-1 | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS44028812 | HTLV-1 | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
| TVIS44034264 | HTLV-1 | ENSG00000017260.20 | protein_coding | ATP2C1 | No | No | 27032 | B4E2Q0 P98194 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ATP2C1 |
|---|---|
| DrugBank ID | DB01373 |
| Drug Name | Calcium |
| Target ID | BE0000218 |
| UniProt ID | P98194 |
| Regulation Type | agonist |
| PubMed IDs | 9787799; 20573858 |
| Citations | Shi X, Chen M, Huvos PE, Hardwicke PM: Amino acid sequence of a Ca(2+)-transporting ATPase from the sarcoplasmic reticulum of the cross-striated part of the adductor muscle of the deep sea scallop: comparison to serca enzymes of other animals. Comp Biochem Physiol B Biochem Mol Biol. 1998 Jun;120(2):359-74.@@Bonza MC, Martin H, Kang M, Lewis G, Greiner T, Giacometti S, Van Etten JL, De Michelis MI, Thiel G, Moroni A: A functional calcium-transporting ATPase encoded by chlorella viruses. J Gen Virol. 2010 Oct;91(Pt 10):2620-9. doi: 10.1099/vir.0.021873-0. Epub 2010 Jun 23. |
| Groups | Nutraceutical |
| Direct Classification | |
| SMILES | [Ca] |
| Pathways | Lidocaine (Antiarrhythmic) Action Pathway; Reteplase Action Pathway; Arachidonic Acid Metabolism; Oxaprozin Action Pathway; Ardeparin Action Pathway; Heparin Action Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; Riboflavin Metabolism; Alprenolol Action Pathway; Naproxen Action Pathway; Procainamide (Antiarrhythmic) Action Pathway; Sphingolipid Metabolism; Tranexamic Acid Action Pathway; Xanthine Dehydrogenase Deficiency (Xanthinuria); Meloxicam Action Pathway; Phenprocoumon Action Pathway; Streptokinase Action Pathway; Phenylketonuria; Gaucher Disease; Fc Epsilon Receptor I Signaling in Mast Cells; Ketorolac Action Pathway; Androgen and Estrogen Metabolism; Acetylsalicylic Acid Action Pathway; Bivalirudin Action Pathway; Aprotinin Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Malate-Aspartate Shuttle; Folate Metabolism; Adenylosuccinate Lyase Deficiency |
| PharmGKB | PA164712582 |
| ChEMBL |
